Based on the results of the BladderPath trial, are you considering multiparametric bladder MRI for all patients with suspected bladder cancer diagnosis prior to TURBT, or for select patients only?   

The mpMRI-directed pathway led to a 45-day reduction in time to correct treatment TTCT for MIBC. Is this a sufficient endpoint to change standard practice? If not, when do you incorporate mpMRI into bladder cancer staging?  

https://ascopubs.org/doi/pdf/10.1200/JCO.23.02398